$YSS

York Space Systems clears design review for Tetra missions

York Space Systems (YSS) announced its Tetra 3 and 4 missions for the U.S. Space Force cleared critical design review, on track for 2026 delivery. The missions, codenamed Nemesis, expand into Geosynchronous Earth Orbit, demonstrating space object tracking and proximity operations for national security. York integrated new sensors and a propulsion system, avoiding major structural changes. The company stated it adds a ninth unique mission set to its defense portfolio.

Original reporting
Published Oct 5, 2026, 1:08 PM UTC
Analysis
AlphAI AI DeskAI-generated
Added to AlphAI Oct 5, 2026, 1:22 PM UTC. Informational, not investment advice.
How this was made
AlphAI summarizes source reporting and applies a structured AI analysis for relevance, timing, sentiment and ticker impact. Always verify material claims with the original publisher.
AlphAI market briefTechnology
Primary signal
$YSS
Bullish
medium confidence
Mentioned
$YSS
Relevance
5/10
AlphAI data visualization · based on investing.com
Decision brief

The 30-second read

$YSSBullishLow
01

Why it matters

Clearing the design review reduces technical risk and keeps the delivery timeline intact, which could improve investor confidence.

02

Market read

Milestone news for a defense contractor; modest positive bias for YSS but limited broader market impact.

03

What to watch

Potential downstream supply‑chain impacts and future follow‑on contracts are not quantified.

Relevance 5/10Novelty 6/10Timing: this week

Background

York Space Systems (NYSE:YSS) is a small‑cap prime contractor for the U.S. Space Force, developing geosynchronous missions.

Company-level read

Ticker impact

$YSSBullishMedium confidence
Context

York Space Systems cleared the Delta Critical Design Review for its Tetra 3 and 4 missions, confirming schedule and technical readiness.

Expected impact

likely modest upside as investors price in reduced execution risk

Evidence & confidence

Milestone news is positive but lacks disclosed dollar value; impact is limited to risk reduction rather than new revenue.

Market effects

demonstrates continued U.S. defense spending on space capabilities, modestly supportive of the defense aerospace sector

limited to U.S. defense and space‑technology investors

minor, as the contract is U.S. government‑focused

Counterpoint

The milestone may be already priced in; without a disclosed contract value, upside could be limited.

Key entities

  • York Space Systems

    U.S. defense aerospace contractor

  • U.S. Space Force

    National security customer for the Tetra missions

Related articles

$YSSMedAI 8/10

York Space Systems (YSS) Cuts Guidance While Backlog Keeps Climbing

York Space Systems (YSS) reported a strong operational quarter but cut its 2026 revenue guidance by $180M due to supply chain delays and government contract shifts. Backlog grew to $592M, but Q2 losses widened to $9.5M. Hedge fund ownership declined, and short interest is at 7.84%. Investors await 2027 revenue conversion from IDIQ task orders and acquisitions.

$YSSHighAI 8/10

York Space Systems (YSS) Q2 2026 Earnings Call Transcript

York Space Systems reported Q2 2026 revenue of $92.5M, up 10% YoY, with adjusted EBITDA loss of $9.5M. Full-year revenue guidance was reduced to $375M-$405M due to supply chain issues and contract timing. The company completed 21 satellite launches and acquired ALL.SPACE for $155M, aiming to expand unmanned systems and secure supply chains.

$YSSMed

York Space Systems Q2 Earnings Call Highlights

York Space Systems (NYSE:YSS) reported Q2 gross margin of 24% versus 11% a year earlier, with gross profit rising to $22.2 million. Backlog was $592 million at June 30. The company guided for mid-20% gross margins in 2026 and said supply-chain delays and removed revenue expectations offset each other. Adjusted EBITDA loss widened to $9.5 million.

$YSSHighAI 9/10

Why York Space Systems Stock Crashed Again Friday

York Space Systems (NYSE: YSS) shares fell 11.2% by 12:35 p.m. ET Friday after missing earnings for a second straight time. Analysts expected Q2 losses of $0.12 per share on $93.9 million sales; York reported losses of $0.31 per share on $92.6 million sales. The company cited 88% contract win rate and $592 million backlog, but lowered 2026 revenue guidance to $375 million to $405 million.